Home Overview Press Room Blog Publications For Students about us
Search

Biotech & Pharma : Displaying 11-20 of 1516


Stop Calling Science a ‘Frontier’ by Leah CeccarelliThe Seattle TimesApril 6th, 2014The notion of a special relationship between Americans and a metaphorical “frontier of science” is troubling because of the historical baggage it subtly imprints on its listeners.
Startup Offering DNA Screening of 'Hypothetical Babies' Raises Fears Over Designer Children[Quotes CGS's Marcy Darnovsky]by Catherine de LangeThe GuardianApril 5th, 2014Anne Morriss and Lee Silver are about to launch a company called Genepeeks that uses the DNA of sperm donors and recipients to create "virtual babies."
Genetic Inheritance: How Much do you Want to Know?by Stuart JeffriesThe GuardianApril 4th, 2014Scientist Sharon Moalem says we will soon be able to alter our children's lives with genetic manipulation – would you do it if you could?
Is it a Boy?by Eloise LyntonThe Harvard IndependentApril 4th, 2014Today, the use of PGD to select gender is a multi-million dollar enterprise. I would argue that prenatal gender selection is worrisome both from an ethical and societal standpoint.
Stem Cell Therapy Patient Dies at 23; Father Seeks Justiceby Stef dela CruzAll VoicesApril 4th, 2014Remaining mum about daughter Kate Tan's death in 2013, Bernard Tan finally decided to break his silence to expose his daughter's stem cell therapist, who is not a licensed physician.
DARPA Carves Out New Division to Entice Biotech Talentby Kelly ServickScienceApril 3rd, 2014The US Department of Defense is making a concerted grasp at biotechnology. DARPA will consolidate biology research scattered across its existing divisions and possibly expand the arsenal of projects.
New Hope for Embattled STAP Cell Researchers?by Monte MorinLos Angeles TimesApril 1st, 2014Just hours after Japanese investigators announced findings of fabrication and misconduct in a highly criticized "acid bath" stem cell study, scientists in Hong Kong said they had partly succeeded in reproducing the controversial experiment.
In Reversal, Genetics Group Says Patients Should Be Allowed to Refuse 'Incidental' Findings by Jennifer Couzin-FrankelScienceApril 1st, 2014Reversing the controversial recommendation they made last year, the American College of Medical Genetics and Genomics now claim that patients should be allowed to “opt out” of learning how their DNA might increase their risk of disease.
CRISPR Reverses Disease Symptoms in Living Animals for First TimeGenetic Engineering NewsMarch 31st, 2014MIT scientists report the use of a CRISPR methodology to cure mice of a rare liver disorder caused by a single genetic mutation.
We May Already Know How we Will Cure Death—But Should we?by Christopher MimsQuartzMarch 29th, 2014A pair of advocates—they do legitimate research too, but their ardor is so intense, it’s hard to call them scientists—believe that they will, within their lifetimes, make ours the first generation of humans to live forever.
Displaying 11-20 of 1516  
< Prev  Next >> 
« First Page Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1936 University Ave, Suite 350, Berkeley, CA 94704 • • (p) 1.510.665.7760 • (F) 1.510.665.8760